Triple-drug Safety Study Reaches Important Milestone

The DOLF project celebrated an important milestone on February 9th. Our Community Based Safety Study of 2-drug vs. 3-drug Therapy for Lymphatic Filariasis completed enrolling and treating 10,000 participants in each of the treatment arms. This achieves the primary objective of the study: measuring the treatment related adverse events following treatment with the 3-drug combination […]